Botanical species · safety record

Garcinia hanburyi

The EFSA Compendium of Botanicals holds 5 constituent measurements and 2 adverse-effect records for Garcinia hanburyi. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Garcinia hanburyi Hook.f.

5Constituent measurements

2Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gambogic acid	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Gambogic acid	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Gambogic acid	Live plants	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Morellin	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Xanthones	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Nephrotoxicity	Urogenital: kidneys	Unspecified	Latex (as part-nature)	Rat (as animal)	Chronic/long term toxicity	Resolve DOI
Teratogenic	Muscle, skeletal	—	—	Rat (as animal)	Reproduction toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Zhao, Li., Zhen, Chen., Wu, Zhaoqiu., Hu, Rong., Zhou, Changlin., Guo, Qinglong. General pharmacological properties, developmental toxicity, and analgesic activity of gambogic acid, a novel natural anticancer agent . Drug and chemical toxicology, 2010, vol. 33, no. 1, p. 88-96. DOI
Qi, Qi., You, Qidong., Gu, Hongyan., Zhao, Li., Liu, Wei., Lu, Na., Guo, Qinglong. Studies on the toxicity of gambogic acid in rats. Journal of ethnopharmacology, 2008, vol. 117, no. 3, p. 433-438. DOI
LIN, LJ., LIN, LZ., PEZZUTO, JM., CORDELL, GA., RUANGRUNGSI, N. ISOGAMBOGIC ACID AND ISOMORELLINOL FROM GARCINIA-HANBURYI. Magnetic resonance in chemistry, 1993, vol. 31, no. 4, p. 340-347. DOI
Reutrakul, Vichai., Anantachoke, Natthinee., Pohmakotr, Manat., Jaipetch, Thaworn., Sophasan, Samaisukh., Yoosook, Chalobon., Kasisit, Jittra., Napaswat, Chanita., Santisuk, Thawatchai., Tuchinda, Patoomratana. Cytotoxic and anti-HIV-1 caged xanthones from the resin and fruits of Garcinia hanburyi . Planta medica, 2007, vol. 73, no. 1, p. 33-40. DOI
Xu, Min., Fu, Wenwei., Zhang, Baojun., Tan, Hongsheng., Xiu, Yanfeng., Xu, Hongxi. Combinative application of pH-zone-refining and conventional high-speed counter-current chromatography for preparative separation of caged polyprenylated xanthones from gamboge . Journal of separation science, 2016, vol. 39, no. 3, p. 559-565. DOI
Tao, Si-Jia., Guan, Shu-Hong., Wang, Wei., Lu, Zhi-Qiang., Chen, Guang-Tong., Sha, Na., Yue, Qing-Xi., Liu, Xuan., Guo, De-An. Cytotoxic Polyprenylated Xanthones from the Resin of Garcinia hanburyi. Journal of natural products, 2009, vol. 72, no. 1, p. 117-124. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature